NL7201692A - - Google Patents

Info

Publication number
NL7201692A
NL7201692A NL7201692A NL7201692A NL7201692A NL 7201692 A NL7201692 A NL 7201692A NL 7201692 A NL7201692 A NL 7201692A NL 7201692 A NL7201692 A NL 7201692A NL 7201692 A NL7201692 A NL 7201692A
Authority
NL
Netherlands
Application number
NL7201692A
Other versions
NL151709B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to DE2233682A priority Critical patent/DE2233682A1/de
Publication of NL7201692A publication Critical patent/NL7201692A/xx
Priority to JP3475673A priority patent/JPS5710106B2/ja
Priority to FR7311783A priority patent/FR2182925B2/fr
Priority to BE129585A priority patent/BE797705R/xx
Priority to US00372313A priority patent/US3856792A/en
Priority claimed from US00372313A external-priority patent/US3856792A/en
Priority to NL7605446.A priority patent/NL166471C/xx
Publication of NL151709B publication Critical patent/NL151709B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NL727201692A 1971-02-09 1972-02-09 Werkwijze ter bereiding van 6-fenyl-4 h-s-triazolo (4,3-a) (1,4) benzodiazepinen. NL151709B (nl)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE2233682A DE2233682A1 (de) 1971-02-09 1972-07-08 2- eckige klammer auf 3-(subst. aminomethyl)-4-h-1,2,4-triazol-4-yl eckige klammer zu -benzophenone, ein verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
JP3475673A JPS5710106B2 (cg-RX-API-DMAC7.html) 1971-02-09 1973-03-28
FR7311783A FR2182925B2 (cg-RX-API-DMAC7.html) 1971-02-09 1973-04-02
BE129585A BE797705R (fr) 1971-02-09 1973-04-03 Derives de benzodiazepines et leur preparation
US00372313A US3856792A (en) 1971-02-09 1973-06-21 2-{8 2-(substituted aminomethyl)-4h-1,2,4-triazol-4-yl{9 benzophenones
NL7605446.A NL166471C (nl) 1971-02-09 1976-05-21 Werkwijze ter bereiding van een therapeutisch preparaat alsmede werkwijze ter bereiding van een daarvoor ge- schikt benzofenonderivaat.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11404971A 1971-02-09 1971-02-09
US24075672A 1972-04-03 1972-04-03
US00372313A US3856792A (en) 1971-02-09 1973-06-21 2-{8 2-(substituted aminomethyl)-4h-1,2,4-triazol-4-yl{9 benzophenones

Publications (2)

Publication Number Publication Date
NL7201692A true NL7201692A (cg-RX-API-DMAC7.html) 1972-08-11
NL151709B NL151709B (nl) 1976-12-15

Family

ID=27381433

Family Applications (1)

Application Number Title Priority Date Filing Date
NL727201692A NL151709B (nl) 1971-02-09 1972-02-09 Werkwijze ter bereiding van 6-fenyl-4 h-s-triazolo (4,3-a) (1,4) benzodiazepinen.

Country Status (14)

Country Link
US (1) US3709898A (cg-RX-API-DMAC7.html)
JP (1) JPS4966679A (cg-RX-API-DMAC7.html)
BE (1) BE779144A (cg-RX-API-DMAC7.html)
BR (1) BR7200590D0 (cg-RX-API-DMAC7.html)
CA (1) CA966123A (cg-RX-API-DMAC7.html)
CH (2) CH570404A5 (cg-RX-API-DMAC7.html)
DE (2) DE2265617C3 (cg-RX-API-DMAC7.html)
DK (1) DK513578A (cg-RX-API-DMAC7.html)
FR (1) FR2124559B1 (cg-RX-API-DMAC7.html)
GB (4) GB1374825A (cg-RX-API-DMAC7.html)
HK (1) HK2580A (cg-RX-API-DMAC7.html)
NL (1) NL151709B (cg-RX-API-DMAC7.html)
SE (1) SE414928B (cg-RX-API-DMAC7.html)
ZA (1) ZA7251B (cg-RX-API-DMAC7.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK139943B (da) * 1971-06-05 1979-05-21 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af triazolo(4,3a)(1,4)benzodiazepin-5N-oxydderivater eller syreadditionssalte deraf.
US3904641A (en) * 1971-06-18 1975-09-09 Yoshitomi Pharmaceutical Triazolothienodiazepine compounds
BE790838A (fr) * 1971-11-02 1973-04-30 Upjohn Co Nouvelles 1-aminophenyl-6-phenyl-s-triazolo (4,3-a) (1,4)- benzodiazepines, leur procede de preparation et medicament les contenant
CA999000A (en) * 1973-02-14 1976-10-26 Jackson B. Hester (Jr.) Process for new benzodiazepines and intermediates
US3879413A (en) * 1973-02-14 1975-04-22 Upjohn Co Process for the production of 6-phenyl-4-H-s-triazolo {8 4,3-a{9 {8 1,4{9 benzodiazepines
US3842090A (en) * 1973-02-14 1974-10-15 Upjohn Co Certain 1-aminomethyl-6-phenyl 4h-s-triazolo(4,3-a)(1,4)benzodiazepines
US4263310A (en) * 1974-03-02 1981-04-21 Boehringer Ingelheim Gmbh 8-Bromo-6-(o-chloro-phenyl)-4H-S-triazolo-[3,4,-c]-thieno-[2,3-e]-1,4-diazepines and salts thereof
GB1517164A (en) * 1974-08-20 1978-07-12 Roche Products Ltd Substituted-phenyl ketones and a process for the manufacture thereof
US4000151A (en) * 1974-09-11 1976-12-28 The Upjohn Company Triazolyl benzophenone compounds
US4000153A (en) * 1974-09-26 1976-12-28 The Upjohn Company Triazolobenzodiazepine intermediates
DE2549686A1 (de) * 1974-11-06 1976-05-13 Parke Davis & Co 4-aryl-1,6-dihydro-trimethylimidazoeckige klammer auf 1,2-a eckige klammer zu pyrazolo eckige klammer auf 4,3-f eckige klammer zu eckige klammer auf 1,4 eckige klammer zu diazepin-verbindungen und verfahren zu deren herstellung
CH601267A5 (cg-RX-API-DMAC7.html) * 1975-12-12 1978-06-30 Ciba Geigy Ag
US4105851A (en) * 1975-09-08 1978-08-08 Parke, Davis & Company 1,3,8-Trimethylimidazopyrazolodiazepine compounds
US4009175A (en) * 1976-03-15 1977-02-22 The Upjohn Company 1-[(Aminooxy)-methyl]-6-substituted-4H-s-triazolo[4,3-a][1,4] benzodiazepines
US4409390A (en) * 1981-07-23 1983-10-11 Hoffmann-La Roche Inc. Pyrrolo[3,4-D][2]Benzazepines
US4405518A (en) * 1981-07-23 1983-09-20 Hoffmann-La Roche Inc. Pyrrolo[3,4-d] [2] benzazepines
US4375473A (en) * 1982-01-04 1983-03-01 The Upjohn Company Method
US4501698A (en) * 1983-03-31 1985-02-26 The Upjohn Company Preparing 1-(hydroxymethyl)-triazolobenzodiazepines and 1-(aminomethyl)-triazolobenzodiazepines
CN103180318B (zh) 2010-05-14 2017-05-10 达那-法伯癌症研究所 雄性避孕组合物以及使用方法
CN103154246B (zh) 2010-05-14 2015-11-25 达那-法伯癌症研究所 用于治疗白血病的组合物和方法
ES2606958T3 (es) 2010-05-14 2017-03-28 Dana-Farber Cancer Institute, Inc. Compuestos de tienotriazolodiazepina para tratar una neoplasia
AU2015201727B2 (en) * 2010-05-14 2018-03-08 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating neoplasia, inflammatory disease and other disorders
WO2012075456A1 (en) 2010-12-02 2012-06-07 Constellation Pharmaceuticals Bromodomain inhibitors and uses thereof
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
WO2012151512A2 (en) 2011-05-04 2012-11-08 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2012174487A2 (en) 2011-06-17 2012-12-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2013184878A1 (en) 2012-06-06 2013-12-12 Constellation Pharmaceuticals, Inc. Benzo [b] isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
BR112016001457A2 (pt) 2013-07-25 2017-08-29 Dana Farber Cancer Inst Inc Inibidores de fatores de transcrição e usos dos mesmos
US11446309B2 (en) 2013-11-08 2022-09-20 Dana-Farber Cancer Institute, Inc. Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors
MX2016009974A (es) 2014-01-31 2016-10-31 Dana Farber Cancer Inst Inc Derivados de diaminopirimidina bencensulfona y sus usos.
EP3099693A4 (en) 2014-01-31 2017-08-16 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
WO2015131113A1 (en) 2014-02-28 2015-09-03 Tensha Therapeutics, Inc. Treatment of conditions associated with hyperinsulinaemia
CN106687463B (zh) 2014-06-20 2019-04-09 星座制药公司 一种乙酰胺类化合物的晶型
WO2016022970A1 (en) 2014-08-08 2016-02-11 Dana-Farber Cancer Institute, Inc. Dihydropteridinone derivatives and uses thereof
RU2017104897A (ru) 2014-08-08 2018-09-10 Дана-Фарбер Кэнсер Инститьют, Инк. Производные диазепана и их применения
UA122130C2 (uk) 2014-10-27 2020-09-25 Тенша Терапеутікс, Інк. Інгібітори бромодомену
CA2986441A1 (en) 2015-06-12 2016-12-15 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
RU2018112953A (ru) 2015-09-11 2019-10-14 Дана-Фарбер Кэнсер Инститьют, Инк. Ацетамидтиенотриазолодиазепины и пути их применения
US11306105B2 (en) 2015-09-11 2022-04-19 Dana-Farber Cancer Institute, Inc. Cyano thienotriazolodiazepines and uses thereof
CR20180336A (es) 2015-11-25 2018-08-06 Dana Farber Cancer Inst Inc Inhibidores de bromodominio bivalentes y usos de los mismos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3413346A (en) * 1966-01-19 1968-11-26 Hoffmann La Roche 2-(2-haloethylamino)-5-halo-benzophenones
US3987052A (en) * 1969-03-17 1976-10-19 The Upjohn Company 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
DE1955349C2 (de) * 1969-11-04 1982-01-28 Takeda Chemical Industries, Ltd., Osaka s-Triazolo [4,3-a] [1,4] benzodiazepine
YU34997B (en) * 1970-03-27 1980-06-30 Hiroyuki Tawada Process for preparing benzodiazepine derivatives

Also Published As

Publication number Publication date
DE2203782A1 (de) 1972-08-24
NL151709B (nl) 1976-12-15
FR2124559A1 (cg-RX-API-DMAC7.html) 1972-09-22
US3709898A (en) 1973-01-09
ZA7251B (en) 1972-09-27
CA966123A (en) 1975-04-15
CH569736A5 (cg-RX-API-DMAC7.html) 1975-11-28
AU3772572A (en) 1973-07-12
DE2265617C3 (de) 1982-05-06
FR2124559B1 (cg-RX-API-DMAC7.html) 1975-08-01
GB1374823A (en) 1974-11-20
GB1374824A (en) 1974-11-20
BE779144A (fr) 1972-08-09
HK2580A (en) 1980-01-25
JPS4966679A (cg-RX-API-DMAC7.html) 1974-06-27
SE414928B (sv) 1980-08-25
BR7200590D0 (pt) 1973-07-17
CH570404A5 (cg-RX-API-DMAC7.html) 1975-12-15
GB1374822A (en) 1974-11-20
DE2265617B2 (de) 1981-07-16
DK513578A (da) 1978-11-17
GB1374825A (en) 1974-11-20
DE2203782C2 (de) 1982-05-13

Similar Documents

Publication Publication Date Title
FR2124559B1 (cg-RX-API-DMAC7.html)
FR2137896A2 (cg-RX-API-DMAC7.html)
DE2252374B2 (cg-RX-API-DMAC7.html)
CS150046B1 (cg-RX-API-DMAC7.html)
FR2123494A1 (cg-RX-API-DMAC7.html)
DK133804C (cg-RX-API-DMAC7.html)
FR2121467B2 (cg-RX-API-DMAC7.html)
FR2083266A5 (cg-RX-API-DMAC7.html)
FR2138555B1 (cg-RX-API-DMAC7.html)
FR2124753A7 (cg-RX-API-DMAC7.html)
FR2124644A5 (cg-RX-API-DMAC7.html)
FR2121772A1 (cg-RX-API-DMAC7.html)
FR2123190B1 (cg-RX-API-DMAC7.html)
FR2123717A5 (cg-RX-API-DMAC7.html)
AU4958672A (cg-RX-API-DMAC7.html)
CS167519B1 (cg-RX-API-DMAC7.html)
FR2125268A1 (cg-RX-API-DMAC7.html)
CS153811B1 (cg-RX-API-DMAC7.html)
CS149129B1 (cg-RX-API-DMAC7.html)
CS153122B1 (cg-RX-API-DMAC7.html)
CS151909B1 (cg-RX-API-DMAC7.html)
CH559744A5 (cg-RX-API-DMAC7.html)
BG17141A1 (cg-RX-API-DMAC7.html)
CH1895572A4 (cg-RX-API-DMAC7.html)
DD97316A1 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: UPJOHN